Interim Medical Director and Fractional CMO Support
In brief
What is fractional CMO and interim Medical Director support?
It gives a company accountable CMO- or Medical-Director-level leadership without requiring an immediate permanent senior hire. Mogens Gisselbaek can advise, execute and work as part of the leadership team across clinical, medical, evidence and governance decisions.
- Best suited to
- Companies that need senior medical ownership before a permanent full-time appointment is justified.
- Typical scope
- Clinical strategy, study and evidence decisions, governance, external-partner leadership, board and investor support, and Medical Affairs ownership.
- Expected outcome
- Clear accountability and an integrated path through the next clinical, medical or organisational value-inflection point.
Expert lead: Mogens Gisselbaek, MD, MSc, physician executive and founder of Gisselbaek Consulting.
Senior medical leadership for biotech, medtech and specialty-pharma companies that need CMO-level judgement and execution before a full-time hire is justified. Gisselbaek Consulting provides fractional Chief Medical Officer and interim Medical Director support across the Nordics, Europe and the UK. The role can be advisory, hands-on or embedded in the leadership team, depending on the situation.
Fractional leadership in practice
Gisselbaek Consulting is currently engaged in a fractional assignment with Abacus Medicine Pharmaceuticals through Brice Group, involving approximately two to three days per week of senior Medical Affairs, medical-strategy and hands-on execution support.
When a fractional or interim model may be the right fit
A fractional or interim model is often relevant when the pipeline has outgrown the internal medical leadership structure; a first-in-human, proof-of-concept, financing, partnering or regulatory milestone is approaching; a senior medical leader is being recruited; or the organisation needs experienced ownership one to three days per week rather than a permanent full-time role.
What clients can expect
Clear medical ownership of the decision in front of the organisation; practical integration with the executive team and external partners; and a stronger connection between clinical strategy, evidence, risk, governance and the company’s next value-inflection point.
Typical situations
- Preparing for first-in-human, proof of concept or a new development phase.
- Aligning the clinical development path with financing, partnering or board decisions.
- Covering temporary senior medical capacity during recruitment, transition or scale-up.
- Providing CMO-level input to protocols, regulatory interactions, governance and vendor oversight.
- Mentoring internal clinical, medical and scientific teams.
Typical deliverables
- Clinical and medical leadership plan.
- Programme governance and decision framework.
- Protocol and study concept input.
- Investor, board or partner-facing medical narrative.
- Risk review and prioritised action plan.
Discuss interim Medical Director or fractional CMO support.
View all five Core Services. Related service: Medical Affairs Strategy.